Literature DB >> 27422528

Delineation of the larynx as organ at risk in radiotherapy: a contouring course within "Rete Oncologica Piemonte-Valle d'Aosta" network to reduce inter- and intraobserver variability.

Domenico Cante1, Edoardo Petrucci2, Cristina Piva3, Valeria Casanova Borca2, Piera Sciacero3, Maurizio Bertodatto3, Caterina Marta3, Pierfrancesco Franco4, Monica Viale5, Giovanni La Valle6, Maria Rosa La Porta3, Oscar Bertetto5.   

Abstract

AIMS: To evaluate the usefulness of a contouring course in reducing inter- and intraobserver variability in the definition of the larynx as organ at risk (OAR).
METHODS: Within the "Rete Oncologica Piemonte-Valle d'Aosta" network, a contouring course focusing on larynx delineation was proposed. Twenty-six radiotherapist technicians (RTTs) experienced in delineating OARs were asked to contour larynx before and after the training. An expert radiation oncologist defined the reference volume for educational purpose. The contoured volumes obtained before and after the course were compared using descriptive statistics (mean value, standard deviation-SD, and coefficient of variation-COV) of volumes and maximum diameters. Conformity index (CI), dice coefficient (DC), and percentage of overlap were used to evaluate the spatial accuracy of the different volumes compared to the reference. Further analysis regarding the variation in the centre of mass (COM) displacement was performed.
RESULTS: The mean volume was 40.4 cm3 before and 65.9 cm3 after the course, approaching the reference value. Mean anteroposterior, laterolateral, and craniocaudal diameters improved, getting each closer to the reference. Moreover, the COM moved approaching reference coordinates. Mean percentage of intersection and DC strongly increased after the course, rising from 57.76 to 93.83 % and from 0.68 to 0.89, respectively. CI enhanced from 0.06 to 0.31.
CONCLUSIONS: This study shows an improvement in larynx definition after the contouring course with lower interobserver variability and major consistency compared to the reference volume. Other specific educational activities may further increase the quality of radiation therapy contouring in this setting.

Entities:  

Keywords:  Contouring; Course; Larynx; Radiotherapy

Mesh:

Year:  2016        PMID: 27422528     DOI: 10.1007/s11547-016-0668-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  34 in total

1.  CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.

Authors:  Charlotte L Brouwer; Roel J H M Steenbakkers; Jean Bourhis; Wilfried Budach; Cai Grau; Vincent Grégoire; Marcel van Herk; Anne Lee; Philippe Maingon; Chris Nutting; Brian O'Sullivan; Sandro V Porceddu; David I Rosenthal; Nanna M Sijtsema; Johannes A Langendijk
Journal:  Radiother Oncol       Date:  2015-08-13       Impact factor: 6.280

2.  Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.

Authors:  Domenico Genovesi; Giampiero Ausili Cèfaro; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Rita Marchese; Umberto Ricardi; Andrea Riccardo Filippi; Theodore Girinsky; Katiuscia Di Biagio; Maurizio Belfiglio; Enza Barbieri; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

3.  [Normal tissue tolerance to external beam radiation therapy: larynx and pharynx].

Authors:  C Debelleix; Y Pointreau; C Lafond; F Denis; G Calais; J-H Bourhis
Journal:  Cancer Radiother       Date:  2010-07-02       Impact factor: 1.018

4.  Contouring of the Pharyngeal Superior Constrictor Muscle (PSCM). A cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group.

Authors:  Daniela Alterio; Delia Ciardo; Lorenzo Preda; Angela Argenone; Orietta Caspiani; Renato Micera; Maria G Ruo Redda; Elvio G Russi; Ernestina Bianchi; Ester Orlandi; Almalina Bacigalupo; Mario Busetto; Domenico Cante; Letizia Deantonio; Vitaliana De Sanctis; Pierfrancesco Franco; Luciana Lastrucci; Laura Marucci; Anna Merlotti; Marinella Molteni; Fabiola Pajar; Monica Rampino; Luigi Santoro; Annamaria Ferrari; Federica Bazzani; Mariangela Caputo; Antonio Laudati; Valentina Borzillo; Sara Falivene; Nicola Simoni; Federica Vigo; Eva Iannacone; Alessia Reali; Alessio Bonanni; Mariavittoria Leone; Luca Giannello; Riccardo Vigna Taglianti; Roberto Orecchia
Journal:  Radiother Oncol       Date:  2014-07-05       Impact factor: 6.280

5.  Multicenter evaluation of different target volume delineation concepts in pediatric Hodgkin's lymphoma. A case study.

Authors:  C Lütgendorf-Caucig; I Fotina; E Gallop-Evans; L Claude; J Lindh; T Pelz; B Knäusl; D Georg; R Pötter; K Dieckmann
Journal:  Strahlenther Onkol       Date:  2012-10-10       Impact factor: 3.621

6.  Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study.

Authors:  Carola Lütgendorf-Caucig; Irina Fotina; Markus Stock; Richard Pötter; Gregor Goldner; Dietmar Georg
Journal:  Radiother Oncol       Date:  2010-12-20       Impact factor: 6.280

7.  Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines.

Authors:  Anke M van Mourik; Paula H M Elkhuizen; Danny Minkema; Joop C Duppen; Corine van Vliet-Vroegindeweij
Journal:  Radiother Oncol       Date:  2010-03-02       Impact factor: 6.280

8.  Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era.

Authors:  Alexander V Louie; George Rodrigues; Jason Olsthoorn; David Palma; Edward Yu; Brian Yaremko; Belal Ahmad; Inge Aivas; Stewart Gaede
Journal:  Radiother Oncol       Date:  2010-02-01       Impact factor: 6.280

9.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.

Authors:  Johannes A Langendijk; Patricia Doornaert; Irma M Verdonck-de Leeuw; Charles R Leemans; Neil K Aaronson; Ben J Slotman
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

10.  Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.

Authors:  Baoqing Li; Dan Li; Derick H Lau; D Gregory Farwell; Quang Luu; David M Rocke; Kathleen Newman; Jean Courquin; James A Purdy; Allen M Chen
Journal:  Radiat Oncol       Date:  2009-11-12       Impact factor: 3.481

View more
  3 in total

1.  Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e.

Authors:  Pierfrancesco Franco; Francesca Arcadipane; Elisabetta Trino; Elena Gallio; Stefania Martini; Giuseppe Carlo Iorio; Cristina Piva; Francesco Moretto; Maria Grazia Ruo Redda; Roberta Verna; Vassiliki Tseroni; Cristina Bona; Gabriele Pozzi; Christian Fiandra; Riccardo Ragona; Oscar Bertetto; Umberto Ricardi
Journal:  Clin Transl Radiat Oncol       Date:  2018-06-11

2.  Reduction of inter-observer variability using MRI and CT fusion in delineating of primary tumor for radiotherapy in lung cancer with atelectasis.

Authors:  Hongjiao Zhang; Chengrui Fu; Min Fan; Liyong Lu; Yiru Chen; Chengxin Liu; Hongfu Sun; Qian Zhao; Dan Han; Baosheng Li; Wei Huang
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

3.  The emerging role of radiation therapists in the contouring of organs at risk in radiotherapy: analysis of inter-observer variability with radiation oncologists for the chest and upper abdomen.

Authors:  Simona Arculeo; Eleonora Miglietta; Fabrizio Nava; Anna Morra; Maria Cristina Leonardi; Stefania Comi; Delia Ciardo; Massimo Sarra Fiore; Marianna Alessandra Gerardi; Matteo Pepa; Simone Giovanni Gugliandolo; Lorenzo Livi; Roberto Orecchia; Barbara Alicja Jereczek-Fossa; Samantha Dicuonzo
Journal:  Ecancermedicalscience       Date:  2020-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.